指南与共识复苏、休克与脓毒症重症综合管理与镇静镇痛

国际心肺移植学会共识会议:心力衰竭相关心源性休克

Consensus statements from the International Society for Heart and Lung Transplantation consensus conference: Heart failure-related cardiogenic shock.
指南 / 共识 · J Heart Lung Transplant · 2023-12-08
一句话结论国际心肺移植学会发布心衰相关心源性休克专家共识,聚焦休克团队、转诊与机械循环支持选择。

该共识由国际心肺移植学会组织54名来自全球42个中心的专家(包括晚期心衰与介入心脏病学家、心胸外科医生、重症心脏病学家、重症医学专家、药师及联合健康专业人员)制定,针对心衰相关心源性休克(HF-CS)定义、诊断与管理达成共识。会议通过会前调查和分组讨论,在缺乏强证据的情况下就休克管理体系(「中心-辐射」模式与分级网络)、转诊时最低数据要求、「休克团队」学科构成、机械循环支持装置选择目标及最佳流量等议题形成专家共识。共识指出心源性休克死亡率接近50%,除及时心肌血运重建外尚无治疗被证实改善生存,且多数研究集中于急性心肌梗死患者,HF-CS证据匮乏。文件希望明确已达成共识的领域并推动未来研究与登记以填补关键知识空白。

要点

  • 心源性休克死亡率接近50%,除及时心肌血运重建外,尚无治疗被证实改善这些患者的生存。
  • 共识由国际心肺移植学会组织54名专家、代表全球42个中心制定,聚焦心衰相关心源性休克(HF-CS)。
  • 讨论议题包括心源性休克管理体系:「中心-辐射」模式与分级网络、转诊时最低数据要求。
  • 讨论议题包括「休克团队」应涉及的学科、机械循环支持装置选择目标及此类装置的最佳流量。
  • 共识为专家共识,旨在明确已达成共识的领域并推动未来研究与登记以提供其他关键知识空白的信息。

适用人群与场景

  • 心衰相关心源性休克(HF-CS)患者;原文指出多数研究集中于急性心肌梗死患者,HF-CS证据匮乏。

处置流程与药物剂量

  • 共识讨论心源性休克管理体系,包括「中心-辐射」模式与分级网络。
  • 共识讨论转诊时需沟通的最低数据水平。
  • 共识讨论「休克团队」应涉及的学科。
  • 共识讨论机械循环支持装置选择的目标及此类装置的最佳流量。

研究设计与关键结果

  • 国际心肺移植学会共识会议有54名参与者(晚期心衰与介入心脏病学家、心胸外科医生、重症心脏病学家、重症医学专家、药师及联合健康专业人员),代表全球42个中心。
  • 共识基于会前调查和分组讨论,在缺乏稳健数据的情况下就预定义的临床问题达成共识。

证据类型、等级与局限

  • 证据类型:国际学会专家共识(共识会议);在缺乏稳健数据的情况下基于专家共识形成。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

指南或共识出处

  • 国际心肺移植学会(International Society for Heart and Lung Transplantation)共识会议共识声明,发表于 J Heart Lung Transplant。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The last decade has brought tremendous interest in the problem of cardiogenic shock. However, the mortality rate of this syndrome approaches 50%, and other than prompt myocardial revascularization, there have been no treatments proven to improve the survival of these patients. The bulk of studies have been in patients with acute myocardial infarction, and there is little evidence to guide the clinician in those patients with heart failure cardiogenic shock (HF-CS). An International Society for Heart and Lung Transplant consensus conference was organized to better define, diagnose, and manage HF-CS. There were 54 participants (advanced heart failure and interventional cardiologists, cardiothoracic surgeons, critical care cardiologists, intensivists, pharmacists, and allied health professionals) with vast clinical and published experience in CS, representing 42 centers worldwide. This consensus report summarizes the results of a premeeting survey answered by participants and the breakout sessions where predefined clinical issues were discussed to achieve consensus in the absence of robust data. Key issues discussed include systems for CS management, including the "hub-and-spoke" model vs a tier-based network, minimum levels of data to communicate when considering transfer, disciplines that should be involved in a "shock team," goals for mechanical circulatory support device selection, and optimal flow on such devices. Overall, the document provides expert consensus on some important issues facing practitioners managing HF-CS. It is hoped that this will clarify areas where consensus has been reached and stimulate future research and registries to provide insight regarding other crucial knowledge gaps.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

参考来源

  1. Baran DA, Billia F, Randhawa V, et al. Consensus statements from the International Society for Heart and Lung Transplantation consensus conference: Heart failure-related cardiogenic shock. J Heart Lung Transplant. 2023. PMID: 38069919. doi:10.1016/j.healun.2023.10.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。